Literature DB >> 33385486

Dissecting miRNA signature in colorectal cancer progression and metastasis.

Xiangjie Huang1, Xinping Zhu1, Yun Yu1, Wangyu Zhu2, Libo Jin3, Xiaodong Zhang4, Shaotang Li4, Peng Zou5, Congying Xie4, Ri Cui6.   

Abstract

Colorectal cancer (CRC) is the third most common cancer and leading cause of cancer related deaths worldwide. Despite recent advancements in surgical and molecular targeted therapies that improved the therapeutic efficacy in CRC, the 5 years survival rate of CRC patients still remains frustratingly poor. Accumulated evidences indicate that microRNAs (miRNAs) play a crucial role in the progression and metastasis of CRC. Dysregulated miRNAs are closely associated with cancerous phenotypes (e.g. enhanced proliferative and invasive ability, evasion of apoptosis, cell cycle aberration, and promotion of angiogenesis) by regulating their target genes. In this review, we provide an updated overview of tumor suppressive and oncogenic miRNAs, circulatory miRNAs, and the possible causes of dysregulated miRNAs in CRC. In addition, we discuss the important functions of miRNAs in drug resistance of CRC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Circulatory miRNAs; Colorectal cancer; Drug resistance; miRNA; miRNA dysregulation

Mesh:

Substances:

Year:  2020        PMID: 33385486     DOI: 10.1016/j.canlet.2020.12.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  [MiR-372-5p regulates PI3K/AKT/CXCL12 signaling pathway by targeting PTEN to promote colorectal cancer cell metastasis].

Authors:  X Shi; K Wei; Y Wu; W Wang; Q Yang; C Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

Review 2.  MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer.

Authors:  Fangfang Yang; Guoyun Xuan; Yixin Chen; Lichao Cao; Min Zhao; Chen Wang; Erfei Chen
Journal:  Front Cell Dev Biol       Date:  2022-04-08

Review 3.  MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.

Authors:  Brian G Jorgensen; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

4.  Shikonin induces cell autophagy via modulating the microRNA -545-3p/guanine nucleotide binding protein beta polypeptide 1 axis, thereby disrupting cellular carcinogenesis in colon cancer.

Authors:  ZhiWei Hu; XinDong Zhou; DeQiang Zeng; JiaJun Lai
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

5.  Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial Cancer.

Authors:  Leyi Ni; Chengyun Tang; Yuning Wang; Jiaming Wan; Morgan G Charles; Zilong Zhang; Chen Li; Ruijie Zeng; Yiyao Jin; Penghao Song; Ming Wei; Bocen Li; Jin Zhang; Zhenghao Wu
Journal:  J Pers Med       Date:  2022-07-17

Review 6.  The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers.

Authors:  Corina-Elena Minciuna; Mihai Tanase; Teodora Ecaterina Manuc; Stefan Tudor; Vlad Herlea; Mihnea P Dragomir; George A Calin; Catalin Vasilescu
Journal:  Comput Struct Biotechnol J       Date:  2022-09-12       Impact factor: 6.155

7.  CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis.

Authors:  Yue Zhang; Duxun Tan; Yi Xie; Linyu Wu; Song Wu; Yuhui Tang; Yongzhou Luo; Xiangsheng Xiao; Xing Li
Journal:  J Oncol       Date:  2022-08-26       Impact factor: 4.501

Review 8.  A review on interplay between small RNAs and oxidative stress in cancer progression.

Authors:  Aparimita Das; Harsha Ganesan; Sushmitha Sriramulu; Francesco Marotta; N R Rajesh Kanna; Antara Banerjee; Fang He; Asim K Duttaroy; Surajit Pathak
Journal:  Mol Cell Biochem       Date:  2021-07-22       Impact factor: 3.396

9.  A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma.

Authors:  Dan-Dan Zhang; Wen-Er Wang; Yu-Shui Ma; Yi Shi; Jie Yin; Ji-Bin Liu; Xiao-Li Yang; Rui Xin; Da Fu; Wen-Jie Zhang
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.